Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0004 Transporter Info | ||||
| Gene Name | ABCG2 | ||||
| Transporter Name | Breast cancer resistance protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Mitoxantrone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 4212 | ||||
| Docking Score | -9.558 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H28N4O6 | ||||
| Molecular Weight | 444.5 | ||||
| Canonical SMILES |
C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
|
||||
| InChI |
InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2
|
||||
| InChIKey | KKZJGLLVHKMTCM-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1 | Rotatable Bond Count | 12 | |
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Nilotinib Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 644241 | ||||
| Docking Score | -13.507 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C28H22F3N7O | ||||
| Molecular Weight | 529.5 | ||||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
|
||||
| InChI |
InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
|
||||
| InChIKey | HHZIURLSWUIHRB-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.9 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | Atorvastatin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 60823 | ||||
| Docking Score | -13.506 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C33H35FN2O5 | ||||
| Molecular Weight | 558.6 | ||||
| Canonical SMILES |
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
|
||||
| InChI |
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
|
||||
| InChIKey | XUKUURHRXDUEBC-KAYWLYCHSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5 | Rotatable Bond Count | 12 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.